Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
October 16, 2023
School-related violence is a major challenge in many low- and middle-income countries yet most countries lack data to answer simple questions that policymakers might ask as precursors to taking action against school-related violence, to understand the consequences of violence, or to monitor progress...
Blog Post
October 16, 2023
Schools should provide a safe and nurturing environment where children are able to learn and thrive. But, in a terrifying perversion of the role school should play in a child’s life, children are often harmed and abused in and around schools by teachers, other school staff, and by fellow students. N...
Blog Post
August 16, 2023
Despite verbal nods to global cooperation, equity, and solidarity, the COVID-19 pandemic laid bare a brutal realpolitik: all countries will put their citizens first and vaccinate their own populations, before offering charitable leftovers beyond their own borders. Sub-Saharan Africa, more than any o...
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
August 10, 2022
PEPFAR’s new strategy—to be released in final form later this year—focuses on how to accelerate progress toward epidemic control amidst continued impacts from COVID-19, while also strengthening core health system functions as well as partnership and coordination efforts; this is precisely what the c...
Jul
1
2020
9:30—11:00 AM ET
June 30, 2020
Procurement processes—which are vital to ensuring an affordable, reliable, and high-quality supply of health products—remain fraught with challenges, as highlighted by the Center for Global Development’s Working Group on the Future of Global Health Procurement. The COVID-19 pandemic is exacerbating ...
Blog Post
May 01, 2020
As low- and middle-income countries are hit by the health and economic effects of COVID-19, the international community is working to mobilize billions of dollars in grants, loans, and debt relief. At the moment, it is difficult to get a full picture of the funding on offer, to whom it is given, and...
Sep
23
2019
12:30—2:00 PM GMT
September 18, 2019
Gautam Rao will talk about his new research, which examines whether evidence changes the beliefs and actions of policy makers. His findings show that policy makers do update their beliefs and do make different policy decisions when presented with new evidence. This research is particularly fasc...